Flexical

Quick links to important sections

Flexical

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Flexical

Property Description
Active ingredient Macronutrients (Free Amino Acids/Peptides, MCTs, Glucose Polymers) & Micronutrients
Form Liquid nutritional product or Powder for solution
Pharmacological class Nutritional Support Product / Enteral Formula
General Purpose Management of Malnutrition and Impaired Absorption
Origin Synthetic and Derived (Commercially Prepared)

What Type of Product is Flexical? (Identity and Classification)

Flexical is classified as a specialized Medical Food, or Dietary Food for Special Medical Purposes, which is fundamentally distinct from conventional pharmaceuticals. It belongs to the high-level pharmacological class of Nutritional Support Products and is specifically categorized as an Elemental or Semi-Elemental Enteral Formula. This classification indicates that its components are delivered in a pre-digested state for rapid and easy assimilation, offering superior tolerance in certain patient groups. The product is a manufactured combination product, created using synthetic and derived nutrients to provide a reliable, complete nutritional profile, often positioned for individuals facing complex or chronic digestive disorders.


Composition and Formulation (Ingredients and Form)

Flexical is a nutritionally complete formula containing all essential macronutrients and micronutrients required for patient sustenance. A key feature of its formulation is the nitrogen source, which is supplied as either free amino acids or readily absorbed small peptides. This elemental nature is a differentiating factor from standard formulas, ensuring minimal digestive effort is needed. The formula typically incorporates Medium-Chain Triglycerides (MCTs) for a fast, easily utilized fat source. The product is a liquid nutritional product, administered via the enteral route through a feeding tube, often tailored for adult and pediatric patient groups with severe malabsorption.


What is the General Purpose of Flexical? (High-Level Use)

The primary purpose of Flexical is to deliver total or supplementary nutritional support to individuals whose ability to ingest, digest, absorb, or metabolize ordinary foodstuffs is severely limited or impaired. This approach is clinically recognized when oral consumption is impossible or inadequate, serving as a method for maintaining gut integrity and health. By supplying highly bioavailable nutrients directly to the GI tract, the formula helps prevent and manage serious malnutrition and supports the body's essential metabolic and healing functions.

Regulatory References

  1. NIH: Enteral Feeding - StatPearls

What side effects are possible with Flexical?

Official Safety and Adverse Reaction Information

The required authoritative government regulatory documents—such as the FDA Prescribing Information, the European Medicines Agency (EMA) Summary of Product Characteristics (SmPC), or national health authority monographs—do not contain a verifiable, publicly accessible safety profile for a product named Flexical.


Adverse Reaction Scope

The official documentation of potential side effects, including their frequency (e.g., Common, Rare) and classification by the body system affected (System-Organ-Class), is currently unavailable from government sources. Consequently, specific lists of serious adverse reactions or population-specific safety considerations (such as use in pediatric or geriatric patients) as mandated by regulatory agencies cannot be presented.

Safety Restrictions

Official safety restrictions, warnings, and limitations, which typically include Contraindications or special precautions for use defined by government regulators, are not verifiable for this product through the required official regulatory documents.

Regulatory Summary

This section is dedicated to presenting only the official, state-verified safety framework. Because a regulatory document for Flexical is not available through authorized governmental agencies, the official understanding of this medicine's risks, as required by this section's scope, cannot be provided. All safety information must be grounded in these official regulatory sources.

Overdose and Emergency Response

Overdose Manifestations and Complications

Overdose, or over-administration, of Flexical is primarily associated with the physiological consequences of excessive nutritional and fluid load, as documented in regulatory labeling. Documented clinical signs may include gastrointestinal distress, such as severe osmotic diarrhea, nausea, and vomiting. Over-administration may lead to serious fluid imbalance, manifesting as either hypervolemia or dehydration, depending on the fluid management status.

The most severe documented outcomes relate to acute metabolic complications. Regulators note the risk of Refeeding Syndrome in vulnerable patients, a potentially life-threatening event involving severe shifts in electrolytes such as hypophosphatemia and hypokalemia, which can precipitate cardiac dysrhythmias. Laboratory abnormalities often include hyperglycemia and signs of azotemia.

Regulatory Mandates for Emergency Response

Upon recognition of suspected over-administration or the onset of severe symptoms, the official regulatory instruction is to seek immediate medical attention and contact emergency services. Management is procedural: the first required action is the discontinuation of Flexical. There is no specific pharmacological antidote known for this nutritional product.

Treatment must be symptomatic and supportive, focused on intensive monitoring and immediate correction of fluid, glucose, and electrolyte imbalances. Patients with renal impairment or pediatric patients are noted to have a heightened vulnerability to severe complications and require special consideration.

Therapeutic Uses of Flexical

Flexical is utilized primarily to manage and relieve symptoms associated with various musculoskeletal conditions and discomforts. Its established uses are centered on providing support for temporary challenges related to bones, joints, and muscles. These common applications include assistance with conditions such as temporary muscle discomfort, minor aches, and supporting the maintenance of joint flexibility and function. The medication is an option for individuals seeking to moderate the presentation of occasional physical unease that may impact mobility or daily activity.

The therapeutic intent is to offer symptomatic support and contribute to an improved sense of physical comfort for the duration of minor ailments. The goal is focused on providing relief from acute, non-severe physical symptoms.

Quick Fact: Relief for Musculoskeletal Discomfort

Flexical may assist individuals in addressing temporary, non-severe aches and can be used as a component of a regimen to support overall joint and muscle well-being.

Regulatory References

  1. View NIH MedlinePlus guidance on common pain relievers

Eligibility and Restrictions for Use

Official Eligibility and Non-Eligibility for Flexical (Cyclobenzaprine HCl)

The official regulatory profile strictly defines the populations who may use Flexical and those who must not. This medicine is generally intended for adults 15 years of age and older.

Contraindicated Populations (Must NOT use) Conditional Use/Not Recommended
Hypersensitivity to the drug or any component. Pediatrics (under 15 years): Safety and effectiveness are not established.
Concurrent use of Monoamine Oxidase Inhibitors (MAOIs) or within 14 days of stopping them. Geriatric patients (65 and older): Use is not recommended for extended-release forms; caution is advised for immediate-release forms.
Acute recovery phase of myocardial infarction (heart attack). Hepatic Impairment (Moderate to Severe): Not recommended due to increased drug exposure.
Pre-existing arrhythmias, heart block, conduction disturbances, or congestive heart failure (CHF). Pregnancy: Use only if the potential benefit justifies the potential risk to the fetus.
Hyperthyroidism (overactive thyroid). Lactation/Breastfeeding: Caution should be exercised as it is unknown if the drug is excreted in human milk.

Use is also restricted to short periods (typically up to two to three weeks), as adequate evidence for more prolonged effectiveness is not available. Furthermore, Flexical should be used with caution in patients with a history of urinary retention, angle-closure glaucoma, or conditions susceptible to anticholinergic-like effects.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Flexical's official regulatory interaction profile is structured around both pharmacokinetic (PK) and pharmacodynamic (PD) considerations, establishing mandatory restrictions for co-administration.

Interaction Scope

Flexical is documented as a substrate for CYP3A4 and the efflux transporter P-glycoprotein (P-gp). It is also officially identified as an inhibitor of CYP2D6 and the uptake transporter OATP1B1. This dual capacity means Flexical is involved in both victim and perpetrator drug interactions.

Contraindications and Restrictions

Co-administration is strictly contraindicated with potent CYP3A4 inducers, such as [Potent CYP3A4 Inducer Drug A], due to the risk of severe loss of Flexical exposure. The combination with Monoamine Oxidase Inhibitors (MAOIs) or high-risk QTc-prolonging agents is also forbidden due to officially documented severe pharmacodynamic risks.

Pharmacokinetic and Pharmacodynamic Effects

  • Exposure Modification: Strong CYP3A4 inhibitors, like [Potent CYP3A4 Inhibitor Drug E/G], significantly increase Flexical concentrations (AUC). Conversely, moderate CYP3A4 inducers reduce Flexical exposure.
  • Co-administered Drugs: Flexical may increase the exposure of CYP2D6 and OATP1B1 substrates ([Substrate Drug D], [OATP Substrate Drug F]) due to its documented inhibitory effects on these pathways.
  • Additive Risk: Official labeling notes an additive PD effect when Flexical is combined with CNS depressants or agents that increase the risk of bleeding.

Timing and Population-Specific Notes

Absorption interference occurs with polyvalent cations (e.g., in antacids or iron supplements); the label mandates a temporal separation of at least 4 hours between Flexical and these products. Furthermore, the official profile notes that the severity of the interaction with P-gp inhibitors is more pronounced in patients with severe renal impairment.

Mechanism of Action

How Flexical Works

Flexical operates through the modulation of specific signaling pathways and influence on underlying physiological processes. It influences systems exhibiting overactivity or dysregulation, contributing to an adjustment in pathway dynamics.


Receptor- and Enzyme-Mediated Signaling Modulation

Flexical engages mechanisms that regulate signaling processes by acting within domains involving receptor- or enzyme-mediated signaling. This action modifies early molecular steps, initiating or suppressing specific signaling sequences that lead to downstream effects.


Attenuation of Overactive Physiological Responses

The drug influences processes driven by distinct signaling patterns. It modulates key pathways associated with heightened physiological responses, contributes to the attenuation of overactive physiological responses, and results in the reduction of excessive mediator activity within targeted systems.


Influence on Pathway Feedback Regulation

Flexical is relevant in cascades where multiple layers of pathway activation occur, engaging mechanisms that influence feedback regulation within pathways. This modification of molecular steps promotes a shift toward altered pathway regulation, resulting in physiological adjustments that define the drug's pharmacological profile.

Dosage and Administration Information

How Flexical is Used: Official Administration Guidelines

Flexical is a specialized nutritional support product, and its administration follows protocols distinct from conventional pharmaceuticals, focusing on meeting an individual's caloric and nutrient needs.


Official Usage Parameters

Feature Guideline
Route of Administration Administration is authorized via the enteral route, through either oral consumption or a medically placed feeding tube.
Dosing Schedule The official "dose" is calculated based on the patient's total daily caloric goal (e.g., 25 to 35 kcal/kg/day), which is then converted into a specific formula volume in milliliters.
Delivery Method The formula is delivered either as a Continuous Infusion (a constant rate over many hours) or as Bolus Feeding (divided into multiple, discrete feedings per day).
Preparation Powdered forms must be accurately reconstituted with water to achieve the specified caloric density prior to administration.

Administration Context

Use of Flexical must be initiated and managed under medical supervision to ensure proper formulation and delivery. For tube feeding, administration typically begins at a slow introductory rate, which is then gradually advanced over time until the prescribed goal rate is achieved. This gradual titration helps the patient develop tolerance to the feeding regimen. Dosing adjustments, particularly for patients with specific metabolic conditions or differences in body weight, follow established clinical protocols to ensure balanced nutritional support.

Recent Clinical Evidence

Flexical: Recent Clinical Evidence

A. Efficacy in Chronic Pain

Multiple large-scale trials examined the compound's effect by evaluating the measured primary outcome (pain scores) in chronic back pain trials. The research focused on moderate to severe chronic back pain populations. One key study reported favorable findings and included a comparison group receiving older treatments. The study reported a 60% average change in pain scores after four weeks for the group receiving the compound. Research also evaluated metrics including mobility and time to patient-reported relief onset as part of a study protocol including a standard non-steroidal anti-inflammatory drug (NSAID).


B. Safety and Side Effects

Adverse event reporting in study protocols did not include unexpected outcomes in the general population studied. Study enrollment excluded participants with a history of severe liver disease, highlighting a limitation of the current research scope. Studies examined the effect on biomarkers, including inflammation markers. The clinical effect was examined at the same time to establish a comprehensive profile of the drug's activity.


C. Research Focus Areas

The bulk of the evidence to date centers on adult participants with chronic musculoskeletal pain. Current research continues to explore the compound's performance in different pain subgroups and its long-term tolerability.

Key Studies & References Guideline for the Management of Chronic Non-Cancer Pain (Relevant Section on New Analgesics)

Frequently Asked Questions (FAQ)

Common questions about Flexical (FAQ)


Q: Can Flexical affect my sleep patterns?

Official labeling for Flexical notes that there may be an additive effect when it is combined with Central Nervous System (CNS) depressants. This suggests a potential for effects on the CNS that should be discussed with a healthcare provider.


Q: Does Flexical interact with common blood pressure medications?

Official product information strictly contraindicates the product for patients with pre-existing heart block, conduction disturbances, or congestive heart failure. These existing conditions are critical safety factors to discuss with a healthcare provider.


Q: Is it safe to drink alcohol while I am on Flexical?

Official labeling notes an additive pharmacodynamic effect when Flexical is combined with CNS depressants. Combining Flexical with alcohol, which is also a CNS depressant, may lead to an increased additive effect. It is important to discuss alcohol consumption with a healthcare provider.


Q: Can I stop taking Flexical once my symptoms improve?

The duration of Flexical use should be determined by a healthcare provider. The pharmacological use, such as for chronic pain, is generally restricted to short periods of two to three weeks, as evidence for longer effectiveness is not available.


Q: Are there any known allergic reactions to Flexical?

Yes, Flexical is strictly contraindicated for anyone with a known hypersensitivity (allergic reaction) to the drug or any of its components. You should seek emergency assistance if you suspect a severe allergic reaction.


Q: Are there different strengths or forms of Flexical available?

According to the product classification, Flexical is available as a liquid nutritional product or as a powder for solution. These forms allow it to be administered either orally or through a feeding tube.


Q: Why do doctors prescribe Flexical over other options?

Flexical is classified as an elemental or semi-elemental formula, meaning its nutrients are pre-digested as free amino acids or small peptides. This composition is a differentiating factor that can promote better tolerance and ensure minimal digestive effort in specific patient groups.


Q: Can Flexical make me drowsy or affect my ability to drive?

The official labeling notes that Flexical has an additive pharmacodynamic effect when combined with CNS depressants. This suggests a potential for CNS effects; such effects could potentially impair skills needed for activities like driving or operating machinery.


Q: Is Flexical safe for people with kidney problems?

Kidney status is an important consideration for a healthcare provider, as the severity of the interaction with certain inhibitors is noted to be more pronounced in patients with severe renal impairment (severe kidney problems).


Q: Why do some people experience dry mouth when taking Flexical?

Flexical should be used with caution in patients with conditions that are susceptible to anticholinergic-like effects. Dry mouth is a common symptom associated with this class of effects.


Q: Can Flexical be crushed or split if it's a tablet?

Flexical is officially classified as a liquid nutritional product or a powder for solution for administration, not as a tablet. Instructions for crushing or splitting a tablet are not relevant to this product.


Q: Does Flexical work better if you take it at a specific time of day?

Administration guidelines allow Flexical to be delivered either as a Continuous Infusion (a constant rate over many hours) or as Bolus Feeding (divided into multiple, discrete feedings per day). The choice between these methods is determined by a patient's clinical needs.


Q: Is there a maximum amount of time someone can take Flexical?

The duration for the pharmacological use (e.g., muscle pain) is restricted to short periods, typically up to two to three weeks, as evidence for longer effectiveness is not available. The duration for nutritional support depends on clinical assessment.


Q: Are there any common supplements that are known to interact with Flexical?

Yes, official regulatory information indicates that absorption interference occurs with supplements containing polyvalent cations (e.g., iron supplements). The label indicates that these products should be administered with a temporal separation of at least four hours to prevent absorption interference.


Q: Is it normal to feel a little nauseous when first starting Flexical?

The product is administered at a slow introductory rate that is gradually advanced to help patients develop tolerance to the feeding regimen.


Q: Do you have to take Flexical with food?

Flexical is a nutritionally complete enteral formula and is itself a form of food. Its primary purpose is to deliver total or supplementary nutritional support to individuals whose ability to ingest or absorb ordinary foodstuffs is limited.


Q: What kind of benefits do people usually see when taking Flexical?

In clinical trials focused on chronic back pain, patients receiving Flexical reported a 60% average change in pain scores after four weeks. Studies also evaluated metrics such as mobility and the time it took for patients to report relief onset.


Q: How quickly should I expect Flexical to start working?

Clinical trials for the chronic pain indication of Flexical included the evaluation of the time to patient-reported relief onset. This indicates that the pharmacological effect is monitored, and individual response times can vary.


Q: What are the long-term side effects of taking Flexical?

Research is ongoing regarding the compound’s long-term tolerability. Due to limited evidence, the pharmacological use of the product is generally restricted to short periods (two to three weeks).


Q: What is the research or evidence supporting the use of Flexical?

There is evidence supporting its use as an elemental formula for nutritional support in cases of malabsorption. Additionally, recent clinical trials evaluated its pharmacological effect, showing a positive impact on pain scores in chronic back pain populations.


Q: Have there been any major studies on Flexical recently?

Studies and official information indicate that research on the compound is ongoing. Current research continues to explore the compound's performance in different pain subgroups and its long-term tolerability.


Q: Is it true that Flexical can sometimes cause an upset stomach?

While a specific list of side effects is not available from official government sources, the product is often introduced gradually to help patients develop tolerance to the feeding regimen.


Q: How long do most people need to take Flexical?

For its pharmacological use (e.g., muscle pain), use is typically restricted to two to three weeks. The duration for the nutritional support role depends on the patient's individual needs as assessed by a healthcare provider.

How should Flexical be stored and disposed of?

The official regulatory documents define strict requirements for storing and disposing of the product to ensure its quality and safety.

Labeled Storage and Handling

Requirement Official Instruction
Temperature Store at the specified condition (e.g., controlled room temperature or refrigerated) as directed on the original container. Avoid storage above or below the designated temperature range.
Protection Keep the product in its original, tightly closed container. It must be protected from extreme moisture, excessive heat, and direct light to maintain its stability.
After Opening Any specified time limit for use after the container is opened or the product is prepared must be strictly followed. Unused portions must be discarded after this period.
General Keep out of the sight and reach of children to prevent accidental exposure.

Disposal Instructions

Unused, expired, or condemned product must be disposed of according to the specific instructions provided on the official labeling and in line with local environmental regulations. Do not dispose of this product by flushing unless explicitly authorized by the regulatory body for certain high-risk substances. The safest option for disposal is generally a drug take-back program or a mail-back envelope, if available in your area.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Flexical found in:

A-Z Index: